Liver Metastasis Unknown Status Phase 4 Trials for Bevacizumab (DB00112)
| Indication | Status | Phase |
|---|---|---|
| DBCOND0029622 (Liver Metastasis) | Unknown Status | 4 |
| clinicaltrials.gov Identifier | Title | Purpose | Drugs |
|---|---|---|---|
| NCT01962376 | Preoperative Chemotherapy With Bevacizumab For Potentially Resectable Gastric Cancer With Liver Metastasis | Treatment |